Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Iktos – Artificial Intelligence for new drug design
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
July 2024 – November 2026 · 4 captures · latest observed messagingPioneering AI and Robotics in Drug Discovery
Iktos combines generative AI, retrosynthesis and robotics to accelerate small-molecule drug discovery from design to preclinical candidate, reducing timelines to under 24 months.